FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.

"FDA to Reconsider Restrictions on Unapproved Peptide Drugs. In a move that could have significant implications for the health and wellness sector, the Food and Drug Administration is set to convene next month to discuss potentially easing restrictions on several peptides, a class of unapproved medications that have gained popularity among some health enthusiasts, particularly those following the recommendations of anti-vaccine advocate Robert F. Kennedy Jr. The peptides in question have been touted as having various health benefits, including anti-aging and weight loss properties, but their safety and efficacy have yet to be fully vetted by regulatory authorities. As the FDA considers relaxing its stance on these unapproved drugs, experts are weighing in on the potential risks and benefits of making them more widely available."

The Food and Drug Administration is meeting next month to consider easing restrictions on several peptides, a group of unapproved drugs popular with followers of Robert F. Kennedy Jr.